Silodosin Capsules 2 mg
Formulation Overview: Precision-filled hard gelatin capsule containing uroselective alpha-1A adrenoceptor antagonist silodosin (2 mg) tailored for renal-adjusted (2 mg), standard (4 mg), or high-efficacy (8 mg) BPH regimens. Formulated with Silodosin 2 mg (2 mg) in Hard Gelatin Capsules dosage form under Sexual Wellness Medication, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-076-SW |
| Catalog Reference | AKP-076 · SN 76 |
| Therapeutic Sector | Sexual Wellness Medication |
| Dosage Form | Hard Gelatin Capsules |
| Active Ingredient | Silodosin 2 mg |
| Strength / Purity | 2 mg |
| Clinical Indication | Dose-titrated symptomatic management of benign prostatic hyperplasia (BPH) and bladder outlet obstruction |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C in a dry place, protect from light and moisture |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |